PET Trial For Alzheimer’s Opens Door For CMS-Backed Research – Phurrough

CMS' decision to fund the full costs of clinical trials assessing positron emission tomography to diagnose Alzheimer's disease marks a step toward the establishment of trial coverage as a viable national coverage decision alternative for the agency